For your skin
The "longevity molecule" of cellular skincare. It supports NAD+ production, which early research links to cellular repair and skin barrier function. Human trial data on topical NMN is still thin -- think of it as a promising frontier ingredient rather than a proven active.
Want the science? Keep reading ↓Mechanism of action
Direct precursor to NAD+ (Nicotinamide Adenine Dinucleotide) that enters cells via the Slc12a8 transporter; activates SIRT1 (the "longevity gene") to stimulate DNA repair, mitochondrial biogenesis, and epidermal barrier reinforcement while suppressing senescent-associated secretory phenotypes (SASP).
Why we tier this anecdotal
2 cited papers across 2 countries. Most of what's cited here is mechanism-level or in-vitro work. We track this as Anecdotal until controlled clinical trials accumulate.
Cited research
Sun Z et al., Small extracellular vesicles loaded with NMN activate NAD+/SIRT3 signaling to delay skin aging, Stem Cell Research & Therapy 2025;16(1):339
Irie J et al., Effect of oral administration of nicotinamide mononucleotide on clinical parameters in healthy men, Endocrine Journal 2020;67(2):153-160 (KCI Indexed)
Sources: 10 clinical journals and regulatory databases across the US, EU, Korea, Japan, and China. Every entry points to a specific document. See methodology for the full list and what each outcome label means.